The ability of human tonsillar lymphoid cells to express growth hormone receptor (hGH-N-R) was analyzed by flow cytometry. FITC-coupled recombinant human growth hormone (hGH-N) was used to reveal the receptors, in combination with phenotype markers. Unlike T cells, tonsillar B cells constitutively express the hGH-N receptor. Quiescent cells separated from activated cells by Percoll-gradient centrifugation bear fewer receptors than activated ones. Activated T cells express hGH-N-R, but the typical germinal centre CD4+CD57 T cells do not. These latter thus appear not to be fully activated. Inside the lymph follicles, the germinal centre CD38 B-cell population and the mantle-zone CD39 B-cell population display similar levels of hGH-N-R expression, but receptor density is lower on dividing dark-zone CD38+CD10 B cells. Different lymphoid-cell populations thus differ markedly in their ability to express the growth hormone receptor, in relation notably to their activation status. This highlights the link between the neuroendocrine system and the active immune defense.
INTRODUCTION
Several studies have revealed two-way connections between the immune and the neuroendocrine systems (Mocchegiani et al., 1990; Murphy et al., 1992; Blalock, 1994; Clarke and Kendall, 1994; Mathison et al., 1994; Ottaway and Hurband, 1994; Fabris et al., 1995;  Hooghe-Peters and Hooghe, 1995; Hooghe et al., 1996) . This highly regulated ensemble forms a network of physiological reactions. Growth hormone produced by the pituitary, under the control of the hypothalamus, is one of the main actors in this network.
Growth hormone (hGH-N) (hGH-N-R) and even produce hGH-N (Kiess and Butenandt, 1985; Badolato et al., 1994 ; see for review Hooghe et al., 1996) . The studies establishing these facts focused solely on crude lymphoid-cell populations, taking no account of the activation or maturation levels of subpopulations present.
Here we have examined expression of hGH-N-R by lymphocyte subpopulations freshly prepared from human tonsillar lymph follicles and by a mitogenactivated lymphocyte population (Gregory et al., 1987; Hardie et al., 1993; Lagresle et al., 1993; MacLennan, 1994; Kremmidiotis and Zola, 1995; Lagresle et al, 1995; Dono et al., 1996) . A peculiar population of T cells has been found inside the germinal centers; these cells are CD4+, most of them are CD57 (Velardi et al., 1986; Bouzahzah et al., 1996a) . On the basis of CD57 expression, we purified them by MACS and analyzed their hGH-N-R expression. Activated cells were separated from quiescent ones by Percoll-gradient centrifugation.
Expression of hGH-N-R was revealed by two different means: with mAb263 (mouse anti-hGH-N-R) and with FITC-labeled hGH-N. Since both methods gave similar results (to be published), we present here the results obtained with hGH-N/FITC. By double labeling (anti-CD/PE and hGH-N/ FITC), we identified cell types and checked their hGH-N-R expression.
MATERIAL AND METHODS

Antibodies
Phycoerythrin (PE)-conjugated anti-CD3, anti-CD 10, anti-CD19, and unconjugated anti-CD19 and anti-CD8 monoclonal antibodies were provided by DAKO (Bouzahzah et al., 1996b) . For this, the cells were incubated with mouse anti-CD19 antibodies before rinsing and adding Dynabeads-coupled anti-mouse IgG (Dynal, Norway) . Labeled B cells were eliminated in a magnetic field. The purity of the T cells usually exceeded 95%, as determined by cytofluorometry (FACScan, Becton-Dickinson, USA).
CD4 lymphocytes were purified similarly with anti-CD19 and anti-CD8 mAbs and Dynabeads.
CD4+CD57 T cells were prepared (Bouzahzah et al., 1995) by means of a magnetic cell sorter (MACS, Becton-Dickinson, USA): Briefly, CD4 cells were incubated for 30 min at 4C with anti-CD57 mAb, then rinsed and placed in contact with PE-conjugated avidin and biotinylated magnetic beads (Sanvertec, The Netherlands). The cells were transferred to a separation column in the magnetic field of a MACS apparatus. CD4+CD57 cells passed through the column, CD57 cells were retained by the magnetic field. The resulting CD57 and CD57-cells preparations were respectively 90% and 95% pure.
Bovine serum albumin (1 mg/ml BSA, Sigma) was conjugated to FITC by the same protocol and used as a negative control.
Isolation of B Cells
Of the nonrosetted cells, around 90% were B cells (CD19+). The concentration of B cells was improved to 95% and 98% of total population by eliminating the contaminating T cells with OKT3 and OKTll and then Dynabeads (Bouzahzah et al., 1995) .
Percoll Gradients Tonsillar cells were separated (Cleary et al., 1995) by density centrifugation into high-and low-density cells on a discontinuous 30/50/100 % Percoll (Pharmacia, Sweden) gradient (1100 g; 12 min). High-density cells were collected at the 50/100 % interface, and low-density cells at the 30/50 % interface. To preserve isotonicity (1 PBS), the Percoll was diluted in PBS. Thus, 100% Percoll is defined as commercially available pure Percoll diluted in 0.1 volume of 10 PBS, 50% Percoll is a 1/1 dilution of Percoll in 1 PBS, and 30% Percoll is obtained by mixing 0.6 volume of Percoll with 1.4 volume of 1 PBS.
Preparation of hGH-N/FITC
Recombinant human GH-N (Kabi, Sweden) was coupled (Badolato et al., 1994; Rapaport et al., 1995) to FITC (Sigma) . This was done as follow: hGH-N (1 mg/ml) was dissolved in 0.1 M sodium bicarbonate buffer, pH 9-9.4. FITC (1 mg/ml) was dissolved in dimethylsulfoxyde (DMSO, Sigma (Figure 1 ). BSA/FITC was used as a negative control (Rapaport et al., 1995) . The binding specificity of hGH-N/FITC has previously been proven by blocking with unlabeled hGH (Igout et al., 1995) . The subsequent experiments were performed with 5 /xg hGH-N/FITC/ml, which enabled us to label a high percentage of hGHN-R while limiting non-specific binding.
Total B-and T-Cell Populations
Crude and cultured lymph-cell populations were (Table IV) at the end of maturation (Kremmidiotis and Zola, 1995) , and finally CD39 after maturation has finished (Lagresle et al., 1993 (Bouzahzah et al., 1995) .
Among the follicular B cells, the dark-zone CD38+CD 10 B cells possess few hGH-N-R. Perhaps proliferation causes B cells to reduce the density of hGH-N-R on their surface: During proliferation, activated cells express less hGH-N-R.
These differences between B and T cells and between resting and proliferating cells were observed on both mixed (crude) and purified lymphoid-cell populations and after centrifugation in Percoll. The results are confirmed by in vitro studies on mitogenactivated lymphoid cells (in preparation). Contamination by other cells bearing the CD of interest does not appear significant, since most of our data were obtained on highly purified B-or T-lymphocyte populations.
Since lymphocyte activation requires antigen recognition and costimulatory signals given by accessory or lymphoid cells, we can now hypothesize that activated cells bear higher numbers of certain receptors rendering them particularly receptive to messages, such as growth hormone, from the neuroendocrine system. Quiescent B cells appear more sensitive to growth hormone signaling than T cells, but activation opens the latter to the influence of growth hormone. The sensitivity of the immune system to signals of the neuroendocrine system thus depends on its stimulation level. These observations reinforce the view that hGH-N is part of the immune system regulation machinery.
